Disorders in lipid metabolism, oxidative stress, and antioxidants in patients with amnestic mild cognitive impairment without major depression
Preprint
Abstract
Background: Amnestic mild cognitive impairment (aMCI) is characterized by changes in lipids and oxidative stress (OS). It is crucial to exclude patients with major depression (MDD) to accurately evaluate these biomarkers in aMCI. Aims: To examine lipid and oxidative stress biomarkers associated with aMCI versus normal controls. Methods: We performed a case-control analysis involving 61 individuals with aMCI (without MDD) and 60 healthy controls. We assessed the severity of aMCI, distress symptoms of old age, and lipid/OS biomarkers. Results: The levels of serum -SH groups were significantly higher in individuals with aMCI, while the levels of malondialdehyde (MDA) were significantly lower in the same group. Serum advanced oxidation protein products, glutathione, and folic acid did not show any notable variations. In individuals with aMCI, we observed an elevated apolipoprotein B (ApoB)/ApoA ratio, as well as decreased levels of high-density lipoprotein cholesterol (HDL), ApoA, and a reverse cholesterol transport (RCT) index. The simultaneous presence of aMCI and subclinical depressive symptoms is marked by elevated levels of triglycerides and ApoB, as well as decreased levels of ApoA and HDL. A significant portion of the variability (24.9%) in a quantitative MCI severity score can be attributed to -SH groups, age (positively), MDA and education (inversely). Discussion: The alterations in MDA and -SH levels in aMCI may potentially disrupt redox signaling, which can affect cell signaling and homeostatic setpoints. The interaction between aMCI and subclinical depressive symptoms can lead to increased atherogenicity and reduced antiatherogenic protection.Keywords
This publication has 54 references indexed in Scilit:
- Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and managementWorld Psychiatry, 2023
- Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challengesAnalytical Biochemistry, 2017
- Prevalence of Depression in Patients With Mild Cognitive ImpairmentJAMA Psychiatry, 2017
- Malondialdehyde Epitopes as Targets of Immunity and the Implications for Atherosclerosis2016
- The Deleterious Effects of Oxidative and Nitrosative Stress on Palmitoylation, Membrane Lipid Rafts and Lipid-Based Cellular Signalling: New Drug Targets in Neuroimmune DisordersMolecular Neurobiology, 2015
- Revised Criteria for Mild Cognitive Impairment May Compromise the Diagnosis of Alzheimer Disease DementiaArchives of Neurology, 2012
- Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairmentAgeing Research Reviews, 2009
- Biological thiols and redox regulation of cellular signal transduction pathways2000
- Development and validation of a geriatric depression screening scale: A preliminary reportJournal of Psychiatric Research, 1982
- “Mini-mental state”Journal of Psychiatric Research, 1975